tiprankstipranks
Advertisement
Advertisement
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
PremiumTipRanks NewswireVERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
13d ago
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
Premium
The Fly
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
13d ago
Veraxa CFO Torsten Burgermeister steps down, Carl von Halem named interim CFO
Premium
The Fly
Veraxa CFO Torsten Burgermeister steps down, Carl von Halem named interim CFO
16d ago
VERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
PremiumTipRanks NewswireVERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
24d ago
Veraxa Biotech initiates cell line development for BiTAC T-cell engager program
Premium
The Fly
Veraxa Biotech initiates cell line development for BiTAC T-cell engager program
24d ago
Why VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals
Premium
TipRanks Newswire
Why VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100